Fusion Pharmaceuticals Inc.
NASDAQ:FUSN
Overview | Financials
Company Name | Fusion Pharmaceuticals Inc. |
Symbol | FUSN |
Currency | USD |
Price | 21.55 |
Market Cap | 1,833,043,000 |
Dividend Yield | 0% |
52-week-range | 2.31 - 21.6 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. John F. Valliant Ph.D. |
Website | https://fusionpharma.com |
An error occurred while fetching data.
About Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD